IRIDEX (NASDAQ:IRIX) specializes in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company's primary focus is on treatments for glaucoma and retinal diseases, aiming to improve the vision and quality of life for patients worldwide. Their product portfolio includes the flagship Cyclo G6 laser system for glaucoma treatment, alongside a wide range of probes and devices designed for various ophthalmic laser procedures. Through ongoing research and development, IRIDEX strives to advance the field of laser therapy and expand its product offerings to meet the evolving needs of clinicians and their patients.